BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Btissame El Hassouni, Giovanna Li Petri, Daniel S.K. Liu, Stella Cascioferro, Barbara Parrino, Waqar Hassan, Patrizia Diana, Asif Ali, Adam E Frampton, Elisa Giovannetti. Pharmacogenetics of treatments for pancreatic cancerExpert Opinion on Drug Metabolism & Toxicology 2019; 15(6): 437 doi: 10.1080/17425255.2019.1620731
2
Heidar Moradnia, Heidar Raissi, Mahnaz Shahabi. The performance of the single-walled carbon nanotube covalently modified with polyethylene glycol to delivery of Gemcitabine anticancer drug in the aqueous environmentJournal of Biomolecular Structure and Dynamics 2020; : 1 doi: 10.1080/07391102.2020.1719204
3
Qian Wei, Yi-Xuan Li, Min Liu, Xin Li, Hua Tang. MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cellsIUBMB Life 2012; 64(8): 697 doi: 10.1002/iub.1051
4
Bart Kramer, Luuk de Haan, Marjolein Vermeer, Thomas Olivier, Thomas Hankemeier, Paul Vulto, Jos Joore, Henriëtte L. Lanz. Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance ProteinsInternational Journal of Molecular Sciences 2019; 20(18): 4647 doi: 10.3390/ijms20184647
5
Xu Ying, Li Jing, Shijie Ma, Qianjun Li, Xiaoling Luo, Zhenguo Pan, Yanling Feng, Pan Feng. GSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 PathwayCancer Cell International 2015; 15(1) doi: 10.1186/s12935-015-0216-y
6
Dina Aggad, Chiara Mauriello Jimenez, Soraya Dib, Jonas G. Croissant, Laure Lichon, Danielle Laurencin, Sébastien Richeter, Marie Maynadier, Shahad K. Alsaiari, Makhlouf Boufatit, Laurence Raehm, Marcel Garcia, Niveen M. Khashab, Magali Gary-Bobo, Jean-Olivier Durand. Gemcitabine Delivery and Photodynamic Therapy in Cancer Cells via Porphyrin-Ethylene-Based Periodic Mesoporous Organosilica NanoparticlesChemNanoMat 2018; 4(1): 46 doi: 10.1002/cnma.201700264
7
Yixing Jiang, Nicole A. DiVittore, James M. Kaiser, Sriram S. Shanmugavelandy, Jennifer L. Fritz, Yasser Heakal, Hephzibah Rani S. Tagaram, Hua Cheng, Myles C. Cabot, Kevin F. Staveley-O'Carroll, Melissa A. Tran, Todd E. Fox, Brian M. Barth, Mark Kester. Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancerCancer Biology & Therapy 2011; 12(7): 574 doi: 10.4161/cbt.12.7.15971
8
Y. Motoo, T. Shimasaki, T. Minamoto. Pancreatology2009; : 33 doi: 10.1007/978-3-642-00152-9_4
9
Anna Leja-Szpak, Jolanta Jaworek, Piotr Pierzchalski, Russel J. Reiter. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1)Journal of Pineal Research 2010; 49(3): 248 doi: 10.1111/j.1600-079X.2010.00789.x
10
Qi-sheng Xia, Yasuhito Ishigaki, Xia Zhao, Takeo Shimasaki, Hideo Nakajima, Hideaki Nakagawa, Tsutomu Takegami, Zhi-hua Chen, Yoshiharu Motoo. Human SMG-1 is Involved in Gemcitabine-Induced Primary microRNA-155/BIC Up-Regulation in Human Pancreatic Cancer PANC-1 CellsPancreas 2011; 40(1): 55 doi: 10.1097/MPA.0b013e3181e89f74
11
Mallaredy Vandana, Sanjeeb K. Sahoo. Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancerBiomaterials 2010; 31(35): 9340 doi: 10.1016/j.biomaterials.2010.08.010
12
Nelson S. Yee, Weiqiang Zhou, Minsun Lee, Rosemary K. Yee. Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinomaCancer Letters 2012; 318(1): 99 doi: 10.1016/j.canlet.2011.12.007
13
NAOKI NAKAYA, YASUHITO ISHIGAKI, HIDEO NAKAJIMA, MANABU MURAKAMI, TAKEO SHIMASAKI, TAKANOBU TAKATA, MAMORU OZAKI, NELSON J. DUSETTI, JUAN L. IOVANNA, YOSHIHARU MOTOO. Meaning of tumor protein 53-induced nuclear protein 1 in the molecular mechanism of gemcitabine sensitivityMolecular and Clinical Oncology 2013; 1(1): 100 doi: 10.3892/mco.2012.8
14
Takafumi Kuroda, Hideaki Ogiwara, Mariko Sasaki, Kazuaki Takahashi, Hiroshi Yoshida, Takako Kiyokawa, Kazuki Sudo, Kenji Tamura, Tomoyasu Kato, Aikou Okamoto, Takashi Kohno. Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinomaGynecologic Oncology 2019; 155(3): 489 doi: 10.1016/j.ygyno.2019.10.002
15
Manabu Mikamori, Daisaku Yamada, Hidetoshi Eguchi, Shinichiro Hasegawa, Tomoya Kishimoto, Yoshito Tomimaru, Tadafumi Asaoka, Takehiro Noda, Hiroshi Wada, Koichi Kawamoto, Kunihito Gotoh, Yutaka Takeda, Masahiro Tanemura, Masaki Mori, Yuichiro Doki. MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal AdenocarcinomaScientific Reports 2017; 7(1) doi: 10.1038/srep42339
16
Xin-yu Huang, Hong-cheng Wang, Zhou Yuan, Ang Li, Mei-lan He, Kai-xing Ai, Qi Zheng, Huan-long Qin. Gemcitabine combined with gum mastic causes potent growth inhibition and apoptosis of pancreatic cancer cellsActa Pharmacologica Sinica 2010; 31(6): 741 doi: 10.1038/aps.2010.54
17
Anna K. Laskowska, Anna K. Puszko, Piotr Sosnowski, Krzysztof Różycki, Piotr Kosson, Joanna Matalińska, Marek Durlik, Aleksandra Misicka. Opioid Tripeptides Hybridized with trans -1-Cinnamylpiperazine as Proliferation Inhibitors of Pancreatic Cancer Cells in Two- and Three-Dimensional in vitro ModelsChemMedChem 2017; 12(19): 1637 doi: 10.1002/cmdc.201700453
18
Takeo Shimasaki, Yasuhito Ishigaki, Yuka Nakamura, Takanobu Takata, Naoki Nakaya, Hideo Nakajima, Itaru Sato, Xia Zhao, Ayako Kitano, Kazuyuki Kawakami, Takuji Tanaka, Tsutomu Takegami, Naohisa Tomosugi, Toshinari Minamoto, Yoshiharu Motoo. Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabineJournal of Gastroenterology 2012; 47(3): 321 doi: 10.1007/s00535-011-0484-9
19
Catherine Burkhart, Daria Fleyshman, Rachael Kohrn, Mairead Commane, Jennifer Garrigan, Vadim Kurbatov, Ilya Toshkov, Rajesh Ramachandran, Laura Martello, Katerina V. Gurova. Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancerOncotarget 2014; 5(22): 11038 doi: 10.18632/oncotarget.2701
20
Kai Masur, Magdalena von Behr, Sander Bekeschus, Klaus-Dieter Weltmann, Christine Hackbarth, Claus-Dieter Heidecke, Wolfram von Bernstorff, Thomas von Woedtke, Lars Ivo Partecke. Synergistic Inhibition of Tumor Cell Proliferation by Cold Plasma and GemcitabinePlasma Processes and Polymers 2015; 12(12): 1377 doi: 10.1002/ppap.201500123
21
Navin Sarin, Florian Engel, Ganna V. Kalayda, Mareike Mannewitz, Jindrich Cinatl, Florian Rothweiler, Martin Michaelis, Hisham Saafan, Christoph A. Ritter, Ulrich Jaehde, Roland Frötschl, Aamir Ahmad. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrestPLOS ONE 2017; 12(7): e0181081 doi: 10.1371/journal.pone.0181081
22
D. Taïeb, S. Giusiano, F. Sebag, M. Marcy, C. de Micco, F. F. Palazzo, N. J. Dusetti, J. L. Iovanna, J. F. Henry, S. Garcia, Colette Taranger-Charpin. Tumor Protein p53-Induced Nuclear Protein (TP53INP1) Expression in Medullary Thyroid Carcinoma: A Molecular Guide to the Optimal Extent of Surgery?World Journal of Surgery 2010; 34(4): 830 doi: 10.1007/s00268-010-0395-6
23
Julien Gommeaux, Carla Cano, Stéphane Garcia, Meritxell Gironella, Sylvia Pietri, Marcel Culcasi, Marie-Josèphe Pébusque, Bernard Malissen, Nelson Dusetti, Juan Iovanna, Alice Carrier. Colitis and Colitis-Associated Cancer Are Exacerbated in Mice Deficient for Tumor Protein 53-Induced Nuclear Protein 1Molecular and Cellular Biology 2007; 27(6): 2215 doi: 10.1128/MCB.01454-06